...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

** Apabetalone (RVX-208) Currently Being Tested in a Phase 3 BETonMACE Cardiovascular Outcomes Trial ** BETonMACE Trial is Fully Enrolled and Top-Line Data Expected Mid-Year 2019 https://clinicaltrials.gov/ct2/show/NCT02586155

Message: Another day another options exercise, this time by Bradley Cann 33,800 @$1.28

I'm viewing these option exercises as extremely positive news, kind of like an insider buying report. The positioning of insiders affairs has to be done prior to any significant news while they are out of blackout. These actions make me think that good news is on the horizon...who knows when. It would be especially nice to see DM, Dr Wong and other senior managers and board members exercise options as well.



New Message
Please login to post a reply